Shoko Miyamoto

Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM

Y. Kumeda, Yuji Kawaguchi, J. Sawa, 2022, Advances in Therapy.

Comparisons of efficacy and safety in insulin glargine and lixisenatide plus glulisine combination therapy with multiple daily injection therapy in Japanese patients with type 2 diabetes

Y. Kumeda, Yuji Kawaguchi, J. Sawa, 2021, Journal of diabetes investigation.

High‐throughput, high‐content screening for novel pigmentation regulators using a keratinocyte/melanocyte co‐culture system

A. Mandinova, V. Kolev, Jun Wang, 2014, Experimental dermatology.

S100A9 is a novel ligand of EMMPRIN that promotes melanoma metastasis.

M. Sakaguchi, N. Huh, A. Motoyama, 2013, Cancer research.

Molecular and Cellular Pathobiology S 100 A 9 Is a Novel Ligand of EMMPRIN That Promotes Melanoma Metastasis

M. Sakaguchi, N. Huh, A. Motoyama, 2012 .

RNA‐binding proteins Rbm38 and Rbm24 regulate myogenic differentiation via p21‐dependent and ‐independent regulatory pathways

Takayuki Morisaki, K. Hidaka, T. Morisaki, 2009, Genes to cells : devoted to molecular & cellular mechanisms.

Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab

K. Yamanishi, N. Kanazawa, M. Natsuaki, 2022, Acta dermato-venereologica.

RNA‐binding proteins Rbm38 and Rbm24 regulate myogenic differentiation via p21‐dependent and ‐independent regulatory pathways

K. Hidaka, T. Morisaki, Donghao Jin, 2009, Genes to cells : devoted to molecular & cellular mechanisms.